期刊
CELL STEM CELL
卷 8, 期 2, 页码 214-227出版社
CELL PRESS
DOI: 10.1016/j.stem.2010.12.010
关键词
-
资金
- Canadian Institutes of Health Research [MOP85057, MOP89359, MOP102490]
- Canada Research Chairs Program
- Ontario Ministry of Research and Innovation
- Ontario Ministry of Training, Colleges, and Universities
- Canada Foundation for Innovation
- Grants-in-Aid for Scientific Research [22370050] Funding Source: KAKEN
Understanding the mechanisms regulating pluripotency in embryonic and induced pluripotent stem cells is required to ensure their safe use in clinical applications. Glycogen synthase kinase-3 (GSK-3) has emerged as an important regulator of pluripotency, based primarily on studies with small-molecule GSK-3 inhibitors. Here, we use mouse embryonic stem cells (ESCs) lacking GSK-3 to demonstrate that a single GSK-3 substrate, beta-catenin, controls the ability of ESCs to exit the pluripotent state and to differentiate into neurectoderm. Unexpectedly, the effects of beta-catenin on pluripotency do not appear to be dependent on TCF-mediated signaling, based on experiments utilizing a beta-catenin C-terminal truncation mutant or highly efficient dominant-negative TCF strategies. Alternatively, we find that stabilized beta-catenin forms a complex with and enhances the activity of Oct-4, a core component of the transcriptional network regulating pluripotency. Collectively, our data suggest previously underappreciated, divergent TCF-dependent and TCF-independent roles for beta-catenin in ESCs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据